U.S.Intraoperative Neuromonitoring Market Overview :
Intraoperative neuromonitoring, also termed as intraoperative neurophysiological monitoring (IONM), is the use of electrophysiological methods to monitor the functional integrity of neural structures during surgical procedures. The purpose of IONM is to reduce neurological damage during surgery and avoid postoperative impairments. The U.S. intraoperative neuromonitoring (IONM) market generated $1,239 million in 2015 and is projected to reach $1,938 million by 2022, growing at a CAGR of 6.6% from 2016 to 2022. The U.S. IONM market is expected to grow at a significant rate during the forecast period, owing to increase in prevalence of chronic disorders, surge in applications of IONM in different surgeries, and rise in risk management through IONM during complex surgeries. Furthermore, stringent regulations for IONM procedures and easy availability of technologically advanced IONM systems & accessories fuel the market growth.
U.S. Intraoperative Neuromonitoring Market Segmentation
The U.S. IONM market is studied based on product & service, source type, application, modality, end user, and state. Based on product & service, the market is segmented into system, accessory, and service. As per source type, the market is bifurcated into insourced monitoring and outsourced monitoring. By end user, the market is categorized into hospital and ambulatory surgical center (ASC). IONM finds its application in spinal surgery, neurosurgery, vascular surgery, ENT surgery, orthopedic surgery, and other surgeries related to the central or peripheral nervous system. IONM modalities include motor evoked potential (MEP), somatosensory evoked potential (SSEP), electroencephalography (EEG), electromyography (EMG), brainstem auditory evoked potential (BAEP), and visual evoked potential (VEP). State-wise, the market is analyzed across California, Texas, New York, Florida, Illinois, Colorado, Louisiana, Michigan, Oklahoma, Alaska, Massachusetts, Delaware, Vermont, Connecticut, North Dakota, New Hampshire, Rhode Island, Maine, West Virginia, Pennsylvania, South Dakota, Minnesota, New Jersey, Ohio, Wisconsin, Maryland, Nebraska, Wyoming, Indiana, Montana, Iowa, Missouri, Oregon, Kentucky, Washington, Kansas, Mississippi, Virginia, Arkansas, Tennessee, South Carolina, Hawaii, Alabama, North Carolina, New Mexico, Idaho, Nevada, Georgia, Arizona, and Utah.
Segment review
Based on source type, the U.S. IONM market is bifurcated as outsourced monitoring and insourced monitoring. The outsourced monitoring segment is expected to grow at the highest CAGR of 10.6% from 2016 to 2022. The outsourced monitoring IONM market witnessed several acquisitions over the past few years. Device manufacturers have acquired outsourcing providers to get a direct link with the hospitals and thus, expand their IONM business; for instance, Nobilis Health Corp. (a healthcare service provider for ambulatory and acute care facilities) acquired Peak Surgeon Innovations, LLC. in 2015.
According to application, the U.S. IONM market is categorized into spinal surgery, neurosurgery, orthopedic surgery, ENT surgery, vascular surgery, and other surgeries. The spinal surgery segment was the highest revenue contributor to the U.S. IONM market and is expected to show dominance during the forecast period, owing to increase in prevalence of spinal surgery in the U.S. and recommended use of IONM during spinal surgery. On the other side, the orthopedic surgery segment is projected to exhibit the fastest market growth during the forecast period, owing to surge in number of orthopedic surgeries with increase in adoption of IONM during orthopedic surgery.
Depending on end user, the U.S. IONM market is segmented into hospital and ambulatory surgical center (ASC). The hospital segment was the major revenue contributor in 2015 and is estimated to show dominance during the forecast period, as critical surgical procedures are preferably performed in hospitals. Furthermore, increase in number of hospitals, growth in number of surgeries, and rise in outsourced monitoring within hospitals drive the growth of the hospital segment. On the other side, the ambulatory surgery center segment is expected to exhibit rapid growth during the forecast period, owing to rise in number of surgeries within ambulatory surgery centers.
The key players profiled in this report include Accurate Monitoring, LLC., Computational Diagnostics, Inc., Intranerve, LLC., Inomed Medizintechnik GmbH, Medtronic Plc, Moberg Research, Inc. (DAYONE MEDICAL, LLC.), Natus Medical Incorporated, Nihon Kohden Corporation, Nuvasive, Inc., and Specialtycare.
Key Benefits for Intraoperative Neuromonitoring Market :
The study provides an in-depth analysis of the market along with the current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2014 to 2022, which is expected to enable the stakeholders to capitalize on the prevailing market opportunities.
A comprehensive analysis of all states of the U.S. is provided to determine the existing opportunities.
The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the U.S. market.
Intraoperative Neuromonitoring Market Report Highlights
| Aspects | Details |
 By Source Type |
|
 By PRODUCT & SERVICES |
|
 By Modality |
|
 By Application |
|
 By End User |
|
 By State |
|
 Key Market Players | Computational Diagnostics, Inc., Nihon Kohden Corporation, Natus Medical Incorporated, Medtronic plc., SpecialtyCare, inomed Medizintechnik GmbH, Morberg Research, Inc. (Dayone Medical, LLC.), NuVasive, Inc., IntraNerve, LLC, Accurate Monitoring LLC |
Analyst Review
Intraoperative neuromonitoring or intraoperative neurophysiological monitoring (IONM) is the use of electrophysiological methods to monitor the functional integrity of neural structures during surgical procedures. The use of IONM devices by hospitals and ambulatory surgical centers during complex surgeries has increased remarkably. Moreover, the market has been moving toward outsourced monitoring to provide advanced treatment options for patients suffering from chronic diseases. Rise in geriatric population, increase in prevalence of chronic disorders, and surge in applications of IONM in different surgeries drive the market. In addition, risk management through IONM during complex surgeries is one of the factors that boosts the growth of the market. Further, majority of the U.S. IONM manufacturers and distributors focus on expanding their presence in the emerging economies. This factor also fuels the market growth.
Loading Table Of Content...
